Table 1 Demographic and lung function test descriptions from progressors and non-progressors whose baseline blood and BAL protein measurements were used in creating models based on the combination of blood and BAL proteins.

From: Identification of a unique temporal signature in blood and BAL associated with IPF progression

 

Non-progressor (N = 20)

Progressor (N = 30)

p value

Age

62.43

65.36

0.2109

Sex (male)

16 (80%)

19 (63.3%)

0.2157

Number never smokers

6 (30%)

11 (36.7%)

0.6343

Number former smokers

13 (65%)

19 (63.3%)

0.9067

Number current smokers

1 (5%)

0

0.2243

FVC% predicted

66.88%

70.94%

0.4153

DLCO% predicted

45.78%

47.74%

0.626

Back to article page